Last update 27 Jan 2026

Human COVID-19 immunoglobulin (pH4)(Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.)

Overview

Basic Info

Drug Type
Immunoglobulin
Synonyms-
Target-
Action
modulators
Mechanism
Immunomodulators
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Post Acute COVID 19 Syndrome
Inactive Indication-
Originator Organization
Sinopharm Group Wuhan Blood Products Co. Ltd.
Active Organization
China National Biotec Group Co., Ltd.China National Biotec Group Co., Ltd.
Inactive Organization
Sinopharm Group Wuhan Blood Products Co. Ltd.Beijing Tiantan Biological Products Corp. Ltd.Beijing Tiantan Biological Products Corp. Ltd.
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Human COVID-19 immunoglobulin (pH4)(Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.)
NCT05173441
/ Not yet recruitingPhase 2
A Randomized, Double-blind, Placebo-controlled Phase II Exploratory Clinical Trial to Evaluate the Efficacy and Safety of Human COVID-19 Immunoglobulin (pH4) for Intravenous Injection (COVID-HIG) in the Treatment of Patients With COVID-19
100 Clinical Results associated with Human COVID-19 immunoglobulin (pH4)(Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Human COVID-19 immunoglobulin (pH4)(Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Human COVID-19 immunoglobulin (pH4)(Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.)
Login to view more data
100 Deals associated with Human COVID-19 immunoglobulin (pH4)(Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 2
United Arab Emirates
Sinopharm Group Wuhan Blood Products Co. Ltd.
30 Dec 2021
COVID-19Phase 2
United Arab Emirates
Beijing Tiantan Biological Products Corp. Ltd.Beijing Tiantan Biological Products Corp. Ltd.
30 Dec 2021
COVID-19Phase 2
United Arab Emirates
China National Biotec Group Co., Ltd.China National Biotec Group Co., Ltd.
30 Dec 2021
Post Acute COVID 19 SyndromePhase 2
United Arab Emirates
China National Biotec Group Co., Ltd.China National Biotec Group Co., Ltd.
30 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free